| Literature DB >> 17142786 |
Céline Eidenschenk1, Emmanuelle Jouanguy, Alexandre Alcaïs, Jean-Jacques Mention, Benoit Pasquier, Ingrid M Fleckenstein, Anne Puel, Laure Gineau, Jean-Claude Carel, Eric Vivier, Françoise Le Deist, Jean-Laurent Casanova.
Abstract
We previously reported the clinical phenotype of two siblings with a novel inherited developmental and immunodeficiency syndrome consisting of severe intrauterine growth retardation and the impaired development of specific lymphoid lineages, including transient CD8 alphabeta T lymphopenia and a persistent lack of blood NK cells. We describe here the elucidation of a plausible underlying pathogenic mechanism, with a cellular phenotype of impaired survival of both fresh and herpesvirus saimiri-transformed T cells, in the surviving child. Clearly, NK cells could not be studied. However, peripheral blood T lymphocytes displayed excessive apoptosis ex vivo. Moreover, the survival rates of CD4 and CD8 alphabeta T cell blasts generated in vitro, and herpesvirus saimiri-transformed T cells cultured in vitro, were low, but not nil, following treatment with IL-2 and IL-15. In contrast, Fas-mediated activation-induced cell death was not enhanced, indicating a selective excess of cytokine deprivation-mediated apoptosis. In keeping with the known roles of IL-2 and IL-15 in the development of NK and CD8 T cells in the mouse model, these data suggest that an impaired, but not abolished, survival response to IL-2 and IL-15 accounts for the persistent lack of NK cells and the transient CD8 alphabeta T lymphopenia documented in vivo. Impaired cytokine-mediated lymphocyte survival is likely to be the pathogenic mechanism underlying this novel form of inherited and selective NK deficiency in humans.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17142786 DOI: 10.4049/jimmunol.177.12.8835
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422